Does MOXONIDINE Cause Basal cell carcinoma? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Basal cell carcinoma have been filed in association with MOXONIDINE. This represents 4.5% of all adverse event reports for MOXONIDINE.
35
Reports of Basal cell carcinoma with MOXONIDINE
4.5%
of all MOXONIDINE reports
0
Deaths
16
Hospitalizations
How Dangerous Is Basal cell carcinoma From MOXONIDINE?
Of the 35 reports, 16 (45.7%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOXONIDINE. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does MOXONIDINE Cause?
Hypotension (97)
Renal impairment (86)
Dizziness (85)
Hyperkalaemia (76)
Abdominal pain (69)
Acute kidney injury (67)
Bradycardia (58)
Drug ineffective (55)
Hypertension (55)
Nausea (50)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which MOXONIDINE Alternatives Have Lower Basal cell carcinoma Risk?
MOXONIDINE vs MS CONTIN
MOXONIDINE vs MULTAQ
MOXONIDINE vs MULTIHANCE
MOXONIDINE vs MUPIROCIN
MOXONIDINE vs MUPIROCIN\MUPIROCIN